MICROBIOME CONNECT IS THE LEADING PARTNERING CONFERENCE FOR MICROBIOME THERAPEUTICS & LIVE BIOTHERAPEUTIC PRODUCTS
It’s a chance for senior executives to address shared challenges around innovative therapeutic development, build meaningful partnerships, and sharpen their R&D and commercial strategies. Bringing together the whole microbiome therapeutics ecosystem – from investors and large pharmaceutical companies through to the most pioneering biotechs, academic institutions and solution providers – it delivers the business-critical information you need to make strategic decisions for your organisation through in-depth case studies and expanded networking opportunities.
With recent approvals for C. difficile from Rebiotix a Ferring Company, Seres Therapeutics and BiomeBank, Microbiome Connect highlights the next wave of cutting-edge science poised to impact this field – with sessions on preclinical and clinical data alongside discussions around manufacturing and diagnostic development.
WHY SHOULD YOU ATTEND?
Investment Trends
Hear from investors and pharma on how to ensure they have confidence in your product and what therapeutic modalities are ripe for investment in 2023 & beyond.
Emerging Therapeutics
Join leading biotechs at the forefront of innovation who are developing pioneering therapeutics across Europe. From Women’s Health & Neuroscience through to Immuno-Oncology & Wound Care, learn how your microbiome drug can meet unmet medical needs.
Bioprocessing Strategies
Create and implement regulatory-adherent manufacturing strategies to bring innovative therapeutics to the clinic. Gain a handle on your CMC and find the partners you need to ensure stability & potency in your manufacturing process.
Biomarker Data
Establish and leverage biomarkers to streamline your route to the clinic, with consideration of how biomarker data sets can make your therapeutic stand above the crowd and drive investment.
HEAR FROM OUR COMMUNITY
Ahead of your visit to Microbiome Connect, hear from some of our partners and attendees on why the series is a must-attend for them - and why you can't miss 2023!
Microbiome Connect has evolved into a "not to miss" event. The opportunity to hear the latest developments across a wide range of companies and key academic/regulatory groups is unique. Additionally, the networking opportunities are second to none. I intend to return.
A great platform to discuss the currently most relevant microbiome topics - a must for microbiome drug developers.
This event was full of brilliant individuals dedicated to the field. It was both inspiring and exciting!
Microbiome Connect USA 2022 was a great opportunity to meet with, learn from and exchange with all stakeholders committed to advancing microbiome therapies and diagnostics.
This event was a great way to get up to date on where the field is and on where it wants to go. Both technology and R&D companies were represented, which was very useful. I appreciated having the two tracks of talks to choose from too.
Fascinating research, stimulating variety of speakers and topics in the field of the Human Microbiome & Therapeutics. The app made the conference easy to navigate, plan and make connections.
Informative sessions, Networking opportunities, Biotech pitch and discussing current and future challenges and opportunities in this emerging space with industry leaders was phenomenal!
If being part of the Microbiome Therapeutics conversation is important to your research or business goals, this is the place to be.
This was an intimate meeting with an excellent focus and presentations on the current state of Microbiome therapies and future prospects in the field.
SNAPSHOT OF 2022 ATTENDEES
EVENT SCHEDULE
The 2023 agenda is here! Fill out the short form to access a copy immediately.
What's new this year?
1) Improved Networking Opportunities
Meet your next collaborator, with a revamped programme allowing for more business critical partnering opportunities than ever with over 8 hours of dedicated networking time
2) More Key Players
Meet the game changers from across the industry, with new companies confirmed for 2023 including Mikrobiomik, Neobe Therapeutics, Integral Solutions, Freya Biosciences, ActoBio Therapeutics and Microviable Therapeutics
3) Business Strategy Sessions
In a market still in its infancy, its critical to gain the strategic insights you need to ensure your business thrives – and we’re bringing together the late-stage companies paving the way in Europe for microbiome therapeutics to share their guidance on running a robust biotech
Subject Access Requests: If you would like a copy of the data/information we hold about you, please email [email protected].
User Deletion Request: If you wish to have your information that is held by Kisaco Research deleted, please email [email protected].
For more information on Kisaco Research policy and procedures, please visit our Privacy Policy.
DOWNLOAD THE AGENDA
2023 SPEAKER FACULTY
Staffan Stromberg
Pedro Correa de Sampaio
Romain Daillere
Jean-Luc Marsat
Sandrine Claus
Benjamin Hadida
Sam Possemiers
Tomas De Wouters
Osnat Tirosh
Juan Basterra
Karine Roget
Denise Kelly
Eric Van der Helm
Anna Chwalibog
Evelina Vågesjö, PhD MBA
Co-founder of and developed the concept during PhD 2011-2016, is now CEO and heading the drug and business development in Ilya Pharma. Also BSc in Management Accounting and finished an MBA 2018. Raised >4.3 M€ in grant funding to the project, lead the first private share issue in 2017 and designed stock option programs for key employees.
Nathalie Corvaia
Chrysi Sergaki
Yuri Martina
Kristen Albright
Steve Emery
Sarah Lebeer
Ruben Vazquez Uribe
Samantha Coulson
Nicolas Pichon
Adam Baker
Harriet Schellekens
Pilar Manrique Ronquillo
Rosanne Hertzberger
Lothar Steidler
Amine Zorgani
Jonathan Swann
Selin Bolca
Johan E.T. van Hylckama Vlieg
Conference Packages
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
TICKET PRICE WILL INCREASE IN:
— June 9, 2023 —
GET INVOLVED
Sponsorship
Let us create a bespoke package based on your specific objectives, and showcase your brand to the microbiome community.
Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding & Networking.
Contact [email protected]
Media & Press
Connecting the microbiome community is essential for progress in the field.
We'd love to hear from you and how we can support one another to connect leaders in the industry and share important insights.
Contact [email protected] if you have any questions. For more information on marketing solutions and digital opportunities, download the Media Kit below.
MICROBIOME CONNECT MEDIA KIT
For more information on webinars, roundtables, content marketing packages, interviews and bespoke opportunities to accelerate microbial innovation with Microbiome Connect, download the Media Kit below.
If you have any questions, please contact Simon Pickles, Senior Commercial Partnerships Manager, [email protected].
POSTER SUBMISSIONS
Are you looking to showcase your recent work to the Microbiome community?
Our dedicated poster session is the perfect way to get your research noticed, ideal for PhD students or Post-Doctoral researchers. In order to present a poster, you need to register as a delegate.
Please note that there is limited space available, and poster space is assigned on a first-come, first-served basis (subject to checks and successful registration). At the event, your presentation will be displayed in a dedicated poster area. The poster presentation session time of taking place is to be confirmed.
Poster abstract submission deadline is 7pm (BST) on Friday June 2, 2023
Posters should be a one page PDF in portrait orientation.
Abstracts received after this time may not be accepted so please submit your abstract as soon as possible! Academics that submit a poster abstract before June 2 2023 get a €100 discount!
Posters should be sized A0 (841mm x 1189mm) in portrait orientation.
If you have any questions please contact [email protected]
Click HERE to make a submission.
PARTNERS
Gold Partners
Biose Industrie
Website: https://www.biose.com/
Biose Industrie is a Contract Development and Manufacturing Organization (CDMO), specialised in Live Biotherapeutic Products. Founded in 1951, Biose Industrie has more than 65 years of experience in the development and production of live bacteria based drugs. Company offers lab development specialised in microbiology (anaerobic, aerobic, GMO strains) and is Drug GMP certified for the manufacturing of API (From 300L to 3 500L), clinical batches and commercial drug products (capsules in blisters or pills, sachets).
ReciBioPharm
Website: https://www.recipharm.com/about-us/bolstering-biologics
Please visit our website for more information.Silver Partner
Microba
Website: https://microba.com/
Microba is a global microbiome company including a precision microbiome analysis service division leveraging superior sampling method, high-throughput sequencing, best-in-class profiler, and the most comprehensive genome reference database.
Combined with advanced analytics, AI expertise and biological knowledge, Microba offers end-to-end research support with robust microbiome analysis and data interpretation, enabling therapeutic, diagnostic discoveries and exploratory microbiome monitoring. Using its platform, Microba’s ongoing population study also provides the largest catalogue of metagenome and associated metadata for data mining, and microbiome associations discovery.
EVENT PARTNER
Bacthera
Website: https://www.bacthera.com/
Bacthera is a Danish/Swiss-based one-stop CDMO in the field of LBP’s, with the overall goal to enable the entire industry to further flourish by introducing industry changing innovations.
From small start-up’s to globally operating pharmaceutical companies, we support our clients developing analytical and manufacturing processes of their strains. With our long experience in handling bacteria in DS and DP production, we can offer tailor-made development and large-scale commercial solutions. Within our facilities, we can handle:
- Strictly and facultative anaerobes
- BSL1/2 categorized strains
- GMO’s
Our customers benefit from background technologies and GMP manufacturing know-how that originate from our mother companies Chr. Hansen & Lonza. In addition, Bacthera’s process expertise, enabling innovations and our world-class analytical services will contribute to our customer’s successful development of their LBP.
CosmosID
Website: www.cosmosid.com
CosmosID® provides end-to-end solutions unlocking the microbiome. A provider of CLIA-certified & ICH-GCP compliant NGS Services and Bioinformatics Solutions, CosmosID offers a range of validated and optimized workflows for research and development.
CosmosID also offers independently validated, industry-leading pipelines for processing metagenomic data, yielding multi-kingdom, strain-level resolution with leading sensitivity and precision. Results can be accessed via CosmosID-HUB, a user-friendly and interactive software for comparative analysis of microbiome data, complete with dynamic charts, visualizations, and statistics.
ProDigest
Website: www.prodigest.eu
ProDigest is a contract research provider with broad range of solutions for in vitro gastrointestinal simulation, both for the upper and the lower gastrointestinal tract, ranging from high throughput screening to in depth investigation of the mode of action and site of effect.
For example, we assist your product development by building up essential know-how in the field of gastrointestinal transit, bioavailability, digestion, metabolism, microbiome, immune modulation and efficacy of probiotics, prebiotics, functional ingredients, and pharmaceuticals, in relation to their fate and function in the body.
Our long-standing experience and expertise in studying the gastrointestinal processes at your service!
JAFRAL
Website: https://jafral.com/
JAFARAL is world’s leading CMO for production of bacteriophages, because it’s has more than 10 years’ experience in manufacturing of phages, other biologics production, large scale production and knowing GMP guidelines. Likewise, JAFRAL has all these years also been involved in plasmid DNA and recombinant proteins production at various levels. JAFRAL’s custom development and manufacturing services have helped developers across the globe to accelerate research and open up their laboratories for ground-breaking science and breakthrough discoveries.
The Hyve
Website: https://www.thehyve.nl/cases/fns-fairspace
Please visit our website for more information.
Venue
Hotel Okura Amsterdam, Ferdinand Bolstraat 333, 1072 LH Amsterdam, Netherlands
Microbiome Connect invites you to join us at Hotel Okura on the 5th-6th July 2023.
Discounted rooms available to attendees here.
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.